An Electrochemical Strategy for the Simultaneous Detection of Doxorubicin and Simvastatin for Their Potential Use in the Treatment of Cancer
The aim of this study was to develop a disposable, simple, fast, and sensitive sensor for the simultaneous electrochemical detection of doxorubicin (DOX) and simvastatin (SMV), which could be used in preclinical studies for the development of new pharmaceutical formulations for drug delivery. Firstl...
Main Authors: | Iulia Rus, Mihaela Tertiș, Cristina Barbălată, Alina Porfire, Ioan Tomuță, Robert Săndulescu, Cecilia Cristea |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-01-01
|
Series: | Biosensors |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-6374/11/1/15 |
Similar Items
-
A Screening Study for the Development of Simvastatin-Doxorubicin Liposomes, a Co-Formulation with Future Perspectives in Colon Cancer Therapy
by: Cristina Ioana Barbălată, et al.
Published: (2021-09-01) -
Time-dependent simvastatin administration enhances doxorubicin toxicity in neuroblastoma
by: Colin C. Anderson, et al.
Published: (2020-01-01) -
Gemcitabine Direct Electrochemical Detection from Pharmaceutical Formulations Using a Boron-Doped Diamond Electrode
by: Iulia Rus, et al.
Published: (2021-09-01) -
A quality by design approach for the development of lyophilized liposomes with simvastatin
by: Alina Porfire, et al.
Published: (2017-11-01) -
Active Tumor-Targeting Nano-formulations Containing Simvastatin and Doxorubicin Inhibit Melanoma Growth and Angiogenesis
by: Giorgiana Negrea, et al.
Published: (2022-04-01)